Pharmafile Logo

Laminar Medica Ltd

Laminar Medica specialises in the design, test, manufacture and qualification of insulated shipping systems, used by the pharmaceutical and biotech industries globally. These systems protect vaccines, drugs, blood and associated medical products from extremes of temperature during transportation.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Unit 4, Tring Industrial Estate Icknield Way, Tring, Hertfordshire, HP23 4JX, United Kingdom
+44 (0)1442 828664

 Latest Content from PMHub 

Surrogate endpoints in HTA: Reflections on my HTAi panel discussion

Calum Jones (Associate Director – Health Economics, Mtech Access) shares his experience of speaking at the 2024 HTAi Annual Meeting. Calum participated in the panel discussion: ‘Surrogate Endpoints in Health...

US and European Market Access for Medical Devices – Free Guide

We are delighted to announce that the second edition of our popular introductory guide: ‘Market access stakeholders and processes for medical devices in key European markets’ is now available. Our...

Say Goodbye to Costly Delays – Origins’ Clinical Trial Participant Simulations Have the Answer!

Lack of Patient Involvement in Clinical Trial Designs Causes Major Issues Low recruitment and retention of clinical trials is a key issue faced by many clinical trials. These can lead...

Unrivalled Convenience – Perks of Virtual Medical Education

Explore the unrivalled convenience of virtual collaboration in medical education with our new series, "Perks of Virtual Medical Education." Learn why this flexible, efficient mode of learning is the future...

OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications

Press Releases | June 24, 2024 | OPEN Health

OPEN Health, a pre-eminent global provider of scientific communications, HEOR and market access, patient engagement, and consulting, today announced a partnership with fusion, an innovative artificial intelligence (AI) and machine...

Unleashing Creativity in Virtual Pharma Engagements

Think outside the box with virtual engagements! Discover how creative asynchronous touchpoints can revolutionize your interactions. Explore everything from OLAs to treatment pathway profiling via a pharma-compliant virtual platform.

Genesis Research Group Announces Participation of CEO David W. Miller in New ITN Business Healthcare Program

Genesis Research Group, led by newly appointed CEO, David W. Miller, is spotlighted in June’s launch of ITN Business’ “Advancing Healthcare” program for its ‘innovate differently’ approach to supporting life...

Alice Beer of ITN Business recently interviewed David W. Miller, CEO of Genesis Research Group, on ‘Advancing Healthcare’

ITN Business invited Genesis Research Group to contribute to a news style programme 'Advancing Healthcare' featuring key opinion leaders in the healthcare sector. Our CEO David W. Miller was one...